NUVB
USDNuvation Bio Inc. Class A Common Stock
$1.810-0.390 (-17.727%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.200
High
$2.230
Low
$1.800
Volume
6.43M
Company Fundamentals
Market Cap
615.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
4.17M
Exchange
NYQ
Currency
USD
52-Week Range
Low $1.54Current $1.810High $3.97
Related News
Analyst Upgrades
Wedbush Maintains Outperform on Nuvation Bio, Maintains $5 Price Target
Wedbush analyst David Nierengarten maintains Nuvation Bio with a Outperform and maintains $5 price target.
View more
BusinessWire
U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer
Approval follows Priority Review and is supported by the robust TRUST clinical program, in which IBTROZI treatment demonstrated high, durable response rates and brain-penetrant efficacy across different lines of
View more
Analyst Upgrades
JMP Securities Reiterates Market Outperform on Nuvation Bio, Maintains $6 Price Target
JMP Securities analyst Silvan Tuerkcan reiterates Nuvation Bio with a Market Outperform and maintains $6 price target.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.